BMRN vs RLMD · P/E 40, rev $1.76B vs $692.3M cap
Biomarin Pharmaceutical Inc (BMRN) versus Relmada Therapeutics Inc (RLMD) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Relmada Therapeutics Inc (RLMD) is a biotechnology company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
RLMD does not have a complete income-statement cache yet.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. RLMD currently screens at market cap $692.3M.
Not investment advice. Open the BMRN and RLMD stock pages for the full models.
Not investment advice.